When can the shingles vaccine, such as Zostavax (zoster vaccine live) or Shingrix (recombinant zoster vaccine), be administered after having shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Shingles Vaccine After Having Shingles

You should wait at least 2 months after the acute shingles episode has resolved before receiving the shingles vaccine, with Shingrix (recombinant zoster vaccine, RZV) being the strongly preferred option over Zostavax. 1, 2, 3

Recommended Waiting Period

  • The minimum interval is 2 months after the shingles episode, allowing for complete resolution of acute symptoms and immune system recovery to optimize vaccine response. 2, 3

  • This 2-month recommendation is based on documented evidence showing this represents the minimum interval between herpes zoster episodes and potential recurrence. 2

  • Different countries have varying recommendations: the USA and Germany recommend waiting until acute symptoms have resolved (minimum 2 months), while Canada, Ireland, and Australia recommend waiting at least 1 year. 2

Why Vaccination After Shingles Is Critical

  • Having one episode of shingles does NOT provide reliable protection against future recurrences. 1, 2

  • The cumulative risk of shingles recurrence is substantial: 2.5% at 2 years, 6.6% at 6 years, and 10.3% at 10 years. 2, 3

  • Vaccination after a shingles outbreak significantly reduces this recurrence risk. 1

Vaccine Choice and Dosing Schedule

For Immunocompetent Adults:

  • Shingrix (RZV) is the preferred vaccine due to superior efficacy (97.2% in adults ≥50 years) compared to the older Zostavax. 1, 4

  • Administer as a 2-dose series with the second dose given 2-6 months after the first dose. 1, 3

  • Protection persists for at least 8 years with minimal waning (maintaining >83.3% efficacy). 1

For Immunocompromised Adults:

  • Shingrix remains the preferred option as it is a non-live vaccine, unlike Zostavax which is contraindicated in immunocompromised patients. 5, 1, 3

  • A shorter schedule may be used with the second dose given 1-2 months after the first dose. 1, 3

  • Consider deferring vaccination until after holding immunosuppressive medication for an appropriate period before and 4 weeks after vaccination to ensure robust immune response. 5, 2

Important Clinical Pitfalls to Avoid

  • Do not confuse the 2-month waiting period after shingles with the 2-6 month interval between vaccine doses—these are separate timeframes. 2

  • Do not delay vaccination beyond the 2-month minimum, as this increases the risk of recurrence without providing additional benefit. 2

  • Do not use live zoster vaccine (Zostavax) in immunocompromised patients—this is an absolute contraindication. 5, 1, 3

  • For patients previously vaccinated with Zostavax, Shingrix should be given at least 2 months after the Zostavax dose, as Zostavax efficacy wanes dramatically over time (only 14.1% by year 10). 1

Expected Side Effects

  • Injection-site reactions are common (9.5% experience grade 3 reactions vs. 0.4% with placebo), including pain, redness, and swelling. 1

  • Systemic symptoms occur in 11.4% of vaccine recipients versus 2.4% in placebo recipients. 1

  • Despite these side effects, no serious safety concerns have been identified in large clinical trials. 1

  • The dropout rate for the second dose is slightly higher in vaccinated individuals (1% increased risk), but completing both doses is essential for optimal protection. 1

References

Guideline

SHINGRIX Vaccination Schedule for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Timing of Shingles Vaccination After a Shingles Outbreak

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Timing of Shingrix Vaccination After Shingles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vaccines for preventing herpes zoster in older adults.

The Cochrane database of systematic reviews, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.